ConductScience.org, home

Paper6817367

Partial improvement in negative schizophrenic symptoms after amphetamine.

Angrist B and 4 others. Psychopharmacology (Berl), 1982. Cited by 90 papers, by iCite.

Cite this record

ConductScience Library. Partial improvement in negative schizophrenic symptoms after amphetamine. Papers, record 6817367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6817367

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Partial improvement in negative schizophrenic symptoms after amphetamine.
PubMed
Journal
Psychopharmacology (Berl)
PubMed
Year
1982
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
90
iCite
Relative citation ratio, by iCite
3.94
iCite
Revised in PubMed
2019-07-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Angrist BB
2Peselow EE
3Rubinstein MM
4Corwin JJ
5Rotrosen JJ

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
DextroamphetamineMajor topic
SchizophreniaMajor topic
Adult
Humans
Middle Aged
Schizophrenic Psychology

References11

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1793562Hyporesponsivity of chronic schizophrenic patients to dextroamphetamine.Arch Gen Psychiatry1976https://conductscience.org/library/papers/793562PubMed
26101544Molecular pathology of schizophrenia: more than one disease process?Br Med J1980https://conductscience.org/library/papers/6101544PubMed
36110217Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6110217PubMed
44630714Provocation of schizophrenic symptoms by intravenous administration of methylphenidate.Arch Gen Psychiatry1973https://conductscience.org/library/papers/4630714PubMed
54835986Central dopamine turnover in schizophrenic syndromes.Arch Gen Psychiatry1974https://conductscience.org/library/papers/4835986PubMed
64578719Behavioral effects of L-dopa in schizophrenic patients.Psychopharmacologia1973https://conductscience.org/library/papers/4578719PubMed
79266Clinical effect of L-dopa on schizophrenia.Curr Ther Res Clin Exp1976https://conductscience.org/library/papers/9266PubMed
8706The effect of L-dopa on young patients with simple schizophrenia, treated with neuroleptic drugs: a double-blind cross-over trial with Madopar and placebo.Psychopharmacologia1975https://conductscience.org/library/papers/706PubMed
91156113Cerebrospinal fluid amine metabolites in acute schizophrenia.Arch Gen Psychiatry1975https://conductscience.org/library/papers/1156113PubMed
104678309Effect of L-dopa in schizophrenia.Folia Psychiatr Neurol Jpn1972https://conductscience.org/library/papers/4678309PubMed
116102776Responses to apomorphine, amphetamine, and neuroleptics in schizophrenic subjects.Psychopharmacology (Berl)1980https://conductscience.org/library/papers/6102776PubMed

Download CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 90 citations.

PMIDTitleJournalYearIn PapersSource
40064751Compound PZ-1262, a 4-isoquinoline-sulfonamide analog of Brexpiprazole, produces potential antidepressant, anxiolytic and procognitive effects in rodent models.Pharmacol Rep2025https://conductscience.org/library/papers/40064751PubMed
39205914Adjunctive methylphenidate extended release in patients with schizophrenia: Protocol of a single-centre fixed dose cross-over open-label trial to improve functional and cognitive outcomes.Contemp Clin Trials Commun2024https://conductscience.org/library/papers/39205914PubMed
26566609The early identification of psychosis: can lessons be learnt from cardiac stress testing?Psychopharmacology (Berl)2016https://conductscience.org/library/papers/26566609PubMed
23756608Adjunctive lisdexamfetamine dimesylate therapy in adult outpatients with predominant negative symptoms of schizophrenia: open-label and randomized-withdrawal phases.Neuropsychopharmacology2013https://conductscience.org/library/papers/23756608PubMed
21243081How have developments in molecular imaging techniques furthered schizophrenia research?Imaging Med2009https://conductscience.org/library/papers/21243081PubMed
19948149The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.Brain Res2010https://conductscience.org/library/papers/19948149PubMed
18427784Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in rats.Psychopharmacology (Berl)2008https://conductscience.org/library/papers/18427784PubMed
17634412A review of the effects of modafinil on cognition in schizophrenia.Schizophr Bull2007https://conductscience.org/library/papers/17634412PubMed
17078926G protein-coupled receptors in major psychiatric disorders.Biochim Biophys Acta2007https://conductscience.org/library/papers/17078926PubMed
16001126The potential role of lamotrigine in schizophrenia.Psychopharmacology (Berl)2005https://conductscience.org/library/papers/16001126PubMed
15495131Amphetamines for schizophrenia.Cochrane Database Syst Rev2004https://conductscience.org/library/papers/15495131PubMed
12829420Neuroadaptations to chronic exposure to drugs of abuse: relevance to depressive symptomatology seen across psychiatric diagnostic categories.Neurotox Res2002https://conductscience.org/library/papers/12829420PubMed
12601500The "two-headed" latent inhibition model of schizophrenia: modeling positive and negative symptoms and their treatment.Psychopharmacology (Berl)2003https://conductscience.org/library/papers/12601500PubMed
8741946Amphetamine and negative symptoms of schizophrenia.Psychopharmacology (Berl)1996https://conductscience.org/library/papers/8741946PubMed
3110848Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.Psychopharmacology (Berl)1987https://conductscience.org/library/papers/3110848PubMed
2860683Amphetamine response and relapse risk after depot neuroleptic discontinuation.Psychopharmacology (Berl)1985https://conductscience.org/library/papers/2860683PubMed
1796130Mood responses of remitted schizophrenics to methylphenidate infusion.Psychopharmacology (Berl)1991https://conductscience.org/library/papers/1796130PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6817367

GET https://conductscience.org/api/papers/v1/6817367/authors